Source: When to Start, What to Use: A Master Class in the Use of First-Line Antiretroviral Therapy

Considering the efficacy, safety, and tolerability factors in determining the appropriate antiretroviral components for your patient’s initial HAART regimen?

This tool enables you to review data from controlled studies on the DHHS and IAS-USA preferred antiretroviral regimens for initial antiretroviral therapy. You can also view a convenient graphical summary of the key data from those studies and print the data and/or download corresponding slides.

Format: Adobe Flash (.swf) | File size: 140 KB | Date posted: 12/6/2007

Source: Managing Drug-Drug Interactions in the Changing Landscape of HIV

Faculty:   Charles W. Flexner, MD Paul Pham, PharmD, BCPS

This interactive tool will enable readers to select a specific antiretroviral agent from a listing of all FDA-approved agents, and either: Display and print a report of the interactions between this drug and other antiretroviral agents and commonly prescribed concomitant medications, or Select multiple concomitant agents from a listing of those most commonly used by HIV-infected patients, and create a report on any interactions between the selected antiretroviral agents and other non-antiretroviral medications. Data last updated May 15, 2008.

Format: Adobe Flash (.swf) | File size: 134 KB | Date posted: 5/15/2007

Source: Dyslipidemia and Other Cardiovascular Risk Factors in HIV: Causes, Clinical Significance, and Management Strategies

Understanding the potential for dyslipidemia or other cardiovascular risk factors while determining an appropriate HAART regimen

This tool enables you to review data from controlled studies on the lipid effects of recommended antiretroviral regimens for initial therapy as well as ‘switch strategies’ in patients on suppressive antiretroviral therapy.

You can also view a convenient graphical summary of the key data from those studies and print the data and/or download corresponding slides.

Format: HTML | Date posted: 1/12/2007

Source: Fine-Tuning Antiretroviral Therapy in HIV-Infected Patients With Virologic Suppression: Strategies to Address Toxicity, Convenience, and Quality of Life

Considering switching a virologically suppressive antiretroviral regimen and want to know the key data associated with the specific switch?

This tool enables you to select specific switches that have been evaluated in controlled studies and then view a convenient graphical summary of the key data from those studies. You can also print the data and/or download slides.

Format: HTML | Date posted: 12/15/2006

Source: Strategies for the Management of Multiclass-Resistant Patients

The tool is designed to provide easy access to data on the characteristics and suitability of the available boosted PIs as potential components of regimens for treatment-experienced patients, using data from prescribing information, clinical studies, and the expert opinion of the author, Joseph J. Eron, Jr, MD

Format: Adobe Flash (.swf) | File size: 76 KB | Date posted: 9/2/2005

Source: Optimizing the NRTI Backbone in HIV-Infected Patients Receiving Antiretroviral Therapy

This interactive tool is intended to help the user assess the characteristics of different NRTI backbones, according to criteria that have been selected for their potential relevance in specific clinical settings.

Format: Adobe Flash (.swf) | File size: 35 KB | Date posted: 8/24/2004

Source: Neurologic Aspects of HIV/AIDS: New Insights and Management Advances

An Interactive Decision Support Tool and Video Resource

A comprehensive guide to neurologic complications directly related to HIV infection of the central nervous system or to opportunistic diseases and neoplasms resulting from immune dysfunction. Browse the complications by name, or search them by presenting symptoms. Includes extensive video clips illustrating components of the neurologic examination, and classic presentations of specific complications.

Format: Adobe Flash (.swf) | File size: 59 KB | Date posted: 5/10/2004

Source: Insulin Resistance and Body Shape Changes in HIV-Infected Patients

This interactive tool allows you to explore the balance between the potential benefits and cardiovascular risks of antiretroviral therapy in the background of various patient and treatment-related risk factors.

Format: Adobe Flash (.swf) | File size: 90 KB | Date posted: 4/22/2004

Source: Cardiovascular Risk Factors and Metabolic Complications in Patients Receiving HAART

An interactive resource that illustrates the impact of different interventions on the 10-year risk of cardiovascular disease in hypothetical patients with different baseline characteristics.

Format: Adobe Flash (.swf) | File size: 47 KB | Date posted: 4/21/2004

Source: Cardiovascular Risk Factors and Metabolic Complications in Patients Receiving HAART

An interactive flowchart offering options for the clinical care of HIV-infected patients who experience protease inhibitor-associated hyperlipidemia.

Format: Adobe Flash (.swf) | File size: 15 KB | Date posted: 4/21/2004